Epithelial transforming growth factor β-activated kinase 1 (TAK1) is activated through two independent mechanisms and

Emily Omori1, Maiko Inagaki, Yuji Mishina

  • 1Department of Environmental and Molecular Toxicology, North Carolina State University, Raleigh, NC 27695-7633, USA.

Insights

Transforming growth factor β-activated kinase 1 (TAK1) regulates reactive oxygen species (ROS) in epithelial tissues. Its activity depends on TAB1 for basal function and TAB2 for stimulus-dependent activation, preventing ROS accumulation and cell death.

Area of Science:

  • Cellular Biology
  • Molecular Signaling
  • Immunology

Background:

  • Cellular redox system dysregulation leads to reactive oxygen species (ROS) accumulation, linked to various diseases.
  • Transforming growth factor β-activated kinase 1 (TAK1) is crucial for innate immunity and in vivo redox regulation.
  • TAK1 deficiency causes ROS accumulation, epithelial cell death, and inflammation.

Purpose of the Study:

  • To elucidate the activation mechanism of TAK1 kinase in epithelial tissues.
  • To define the distinct roles of TAK1-binding protein 1 (TAB1) and TAB2 in TAK1 regulation.
  • To understand how TAK1 controls redox balance in epithelial cells.

Main Methods:

  • Generation and analysis of epithelial-specific TAB1 and TAB2 double-knockout mouse models.
  • Assessment of TAK1 kinase activity in knockout mice.
  • Evaluation of reactive oxygen species (ROS) levels and epithelial tissue integrity.

Main Results:

  • Epithelial-specific knockout of both TAB1 and TAB2 mimicked TAK1 knockout phenotypes.
  • TAB1 is essential for the basal, phosphorylation-dependent activity of TAK1.
  • Loss of both TAB1 and TAB2 significantly reduced TAK1 activity and increased ROS accumulation in epithelial tissues.

Conclusions:

  • Epithelial TAK1 activation involves two distinct mechanisms: TAB1-dependent basal activity and TAB2-mediated stimulus-dependent activation.
  • This dual regulation by TAB1 and TAB2 is critical for maintaining epithelial redox homeostasis.
  • Dysregulation of these TAK1 activation pathways contributes to ROS-associated pathologies.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...